$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma 원문보기

International journal of nanomedicine, v.15, 2020년, pp.8427 - 8436  

Wi, Tae In (Department of Immunology, School of Medicine, Konkuk University , Chungju 380-701 , South Korea) ,  Won, Ji Eun (Department of Immunology, School of Medicine, Konkuk University , Chungju 380-701 , South Korea) ,  Lee, Chan Mi (Department of Immunology, School of Medicine, Konkuk University , Chungju 380-701 , South Korea) ,  Lee, Jeong-Won (Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea) ,  Kang, Tae Heung (Department of Immunology, School of Medicine, Konkuk University , Chungju 380-701 , South Korea) ,  Shin, Byung Cheol (Bio) ,  Han, Hee Dong (Department of Immunology, School of Medicine, Konkuk University , Chungju 380-701 , South Korea) ,  Park, Yeong-Min (Department of Immunology, School of Medicine, Konku)

Abstract AI-Helper 아이콘AI-Helper

BackgroundEpithelial ovarian cancer (EOC) is a fatal gynecologic malignancy that is usually treated with chemotherapy after surgery. However, patients who receive chemotherapy experience severe side effects because of the inherent toxicity and high dose of chemotherapeutics. To overcome these issues...

Keyword

참고문헌 (33)

  1. 1. Brett MR , Jennifer B. P , Thomas A. S . Epidemiology of ovarian cancer: a review . Cancer Biol Med . 2017 ; 14 ( 1 ): 9 ? 32 . doi: 10.20892/j.issn.2095-3941.2016.0084 . 28443200 

  2. 2. Tsao Y , Creedy DK . Auricular acupressure: reducing side effects of chemotherapy in women with ovarian cancer . Support Care Cancer . 2019 ; 27 ( 11 ): 4155 ? 4163 . doi: 10.1007/s00520-019-04682-8 . 30796521 

  3. 3. Cristea M , Han E , Salmon L , Morgan RJ . Practical considerations in ovarian cancer chemotherapy . Ther Adv Med Oncol . 2010 ; 2 ( 3 ): 175 ? 187 . doi: 10.1177/1758834010361333 . 21789133 

  4. 4. Virani NA , Thavathiru E , McKernan P , Moore K , Benbrook DM , Harrison RG . Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer . Cancer Lett . 2018 ; 425 : 174 ? 182 . doi: 10.1016/j.canlet.2018.03.027 . 29574275 

  5. 5. Yahara K , Ohguri T , Imada H , et al. Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy . J Radiat Res . 2013 ; 54 ( 2 ): 322 ? 329 . doi: 10.1093/jrr/rrs108 . 23179378 

  6. 6. Hu J , Shen Y , Zhang G , et al. Effect of acupoint therapies on chemotherapy-induced nausea and vomiting: A systematic review protocol . Medicine . 2019 ; 98 ( 37 ): e17109 . doi: 10.1097/md.0000000000017109 . 31517844 

  7. 7. Ruggeri C , Gioffre S , Achilli F , Colombo GI , D’Alessandra Y . Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients . Heart Fail Rev . 2018 ; 23 ( 1 ): 109 ? 122 . doi: 10.1007/s10741-017-9653-0 . 28944400 

  8. 8. Jung SH , Kim SK , Jung SH , et al. Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes . Colloids Surf B Biointerfaces . 2010 ; 76 ( 2 ): 434 ? 440 . doi: 10.1016/j.colsurfb.2009.12.002 . 20036109 

  9. 9. Krauss AC , Gao X , Li L , et al. FDA approval summary: (Daunorubicin and Cytarabine) liposome for injection for the treatment of adults with high-risk acute myeloid leukemia . Clin Cancer Res . 2019 ; 25 ( 9 ): 2685 ? 2690 . doi: 10.1158/1078-0432.ccr-18-2990 . 30541745 

  10. 10. Barenholz Y . Doxil ® ― the first FDA-approved nano-drug: lessons learned . J Control Release . 2012 ; 160 ( 2 ): 117 ? 134 . doi: 10.1016/j.jconrel.2012.03.020 . 22484195 

  11. 11. Pistollato F , Calderon Iglesias R , Ruiz R , et al. The use of natural compounds for the targeting and chemoprevention of ovarian cancer . Cancer Lett . 2017 ; 411 : 191 ? 200 . doi: 10.1016/j.canlet.2017.09.050 . 29017913 

  12. 12. Rajesh E , Sankari LS , Malathi L , Krupaa JR . Naturally occurring products in cancer therapy . J Pharm Bioallied Sci . 2015 ; 7 ( Suppl 1 ): S181 ? 183 . doi: 10.4103/0975-7406.155895 . 26015704 

  13. 13. Wei X , Shamrakov D , Nudelman S , et al. Cardinal role of intraliposome doxorubicin-sulfate nanorod crystal in doxil properties and performance . ACS Omega . 2018 ; 3 ( 3 ): 2508 ? 2517 . doi: 10.1021/acsomega.7b01235 . 30023837 

  14. 14. Iwasaki K , Zheng YW , Murata S , et al. Anticancer effect of linalool via cancer-specific hydroxyl radical generation in human colon cancer . World J Gastroenterol . 2016 ; 22 ( 44 ): 9765 ? 9774 . doi: 10.3748/wjg.v22.i44.9765 . 27956800 

  15. 15. Pereira I , Severino P , Santos AC , Silva AM , Souto EB . Linalool bioactive properties and potential applicability in drug delivery systems . Colloids Surf B Biointerfaces . 2018 ; 171 : 566 ? 578 . doi: 10.1016/j.colsurfb.2018.08.001 . 30098535 

  16. 16. Kalepu S , Nekkanti V . Insoluble drug delivery strategies: review of recent advances and business prospects . Acta Pharm Sin B . 2015 ; 5 ( 5 ): 442 ? 453 . doi: 10.1016/j.apsb.2015.07.003 . 26579474 

  17. 17. Han HD , Cho YJ , Cho SK , et al. Linalool-incorporated nanoparticles as a novel anticancer agent for epithelial ovarian carcinoma . Mol Cancer Ther . 2016 ; 15 ( 4 ): 618 ? 627 . doi: 10.1158/1535-7163.mct-15-0733-t . 26861249 

  18. 18. Desale SS , Soni KS , Romanova S , Cohen SM , Bronich TK . Targeted delivery of platinum-taxane combination therapy in ovarian cancer . J Control Release . 2015 ; 220 ( Pt B ): 651 ? 659 . doi: 10.1016/j.jconrel.2015.09.007 . 26381902 

  19. 19. Bayat Mokhtari R , Homayouni TS , Baluch N , et al. Combination therapy in combating cancer . Oncotarget . 2017 ; 8 ( 23 ): 38022 ? 38043 . doi: 10.18632/oncotarget.16723 . 28410237 

  20. 20. Pritchard JR , Bruno PM , Gilbert LA , Capron KL , Lauffenburger DA , Hemann MT . Defining principles of combination drug mechanisms of action . Proc Natl Acad Sci U S A . 2013 ; 110 ( 2 ): E170 ? 179 . doi: 10.1073/pnas.1210419110 . 23251029 

  21. 21. Kang Y , Hu W , Ivan C , et al. Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer . J Natl Cancer Inst . 2013 ; 105 ( 19 ): 1485 ? 1495 . doi: 10.1093/jnci/djt210 . 24062525 

  22. 22. Lu C , Han HD , Mangala LS , et al. Regulation of tumor angiogenesis by EZH2 . Cancer Cell . 2010 ; 18 ( 2 ): 185 ? 197 . doi: 10.1016/j.ccr.2010.06.016 . 20708159 

  23. 23. Byeon Y , Lee JW , Choi WS , et al. CD44-targeted PLGA nanoparticles incorporating paclitaxel and FAK siRNA overcome chemoresistance in epithelial ovarian cancer . Cancer Res . 2018 ; 78 ( 21 ): 6247 . doi: 10.1158/0008-5472.can-17-3871 . 30115698 

  24. 24. Kwon HJ , Byeon Y , Jeon HN , Cho SH , Han HD , Shin BC . Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect . J Control Release . 2015 ; 216 : 132 ? 139 . doi: 10.1016/j.jconrel.2015.08.002 . 26247553 

  25. 25. Han HD , Jeon YW , Kwon HJ , et al. Therapeutic efficacy of doxorubicin delivery by a CO2 generating liposomal platform in breast carcinoma . Acta Biomater . 2015 ; 24 : 279 ? 285 . doi: 10.1016/j.actbio.2015.06.019 . 26102337 

  26. 26. Won JE , Byeon Y , Wi TI , et al. Enhanced antitumor immunity using a tumor cell lysate-encapsulated CO2-generating liposomal carrier system and photothermal irradiation . ACS Appl Bio Mater . 2019 ; 2 ( 6 ): 2481 ? 2489 . doi: 10.1021/acsabm.9b00183 . 

  27. 27. Ou Y-C , Wen X , Johnson CA , et al. Multimodal multiplexed immunoimaging with nanostars to detect multiple immunomarkers and monitor response to immunotherapies . ACS Nano . 2020 ; 14 ( 1 ): 651 ? 663 . doi: 10.1021/acsnano.9b07326 . 31851488 

  28. 28. Mayer LP , Dyer CA , Eastgard RL , Hoyer PB , Banka CL . Atherosclerotic lesion development in a novel ovary-intact mouse model of perimenopause . Arterioscler Thromb Vasc Biol . 2005 ; 25 ( 9 ): 1910 ? 1916 . doi: 10.1161/01.ATV.0000175767.46520.6a . 15994440 

  29. 29. Cortez AJ , Tudrej P , Kujawa KA , Lisowska KM . Advances in ovarian cancer therapy . Cancer Chemother Pharmacol . 2018 ; 81 ( 1 ): 17 ? 38 . doi: 10.1007/s00280-017-3501-8 . 29249039 

  30. 30. Chamberlin SR , Blucher A , Wu G , et al. Natural product target network reveals potential for cancer combination therapies . Front Pharmacol . 2019 ; 10 : 557 . doi: 10.3389/fphar.2019.00557 . 31214023 

  31. 31. Golombek SK , May J-N , Theek B , et al. Tumor targeting via EPR: strategies to enhance patient responses . Adv Drug Deliv Rev . 2018 ; 130 : 17 ? 38 . doi: 10.1016/j.addr.2018.07.007 . 30009886 

  32. 32. Sun R , Liu Y , Li S-Y , et al. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells . Biomaterials . 2015 ; 37 : 405 ? 414 . doi: 10.1016/j.biomaterials.2014.10.018 . 25453968 

  33. 33. Barui S , Saha S , Mondal G , Haseena S , Chaudhuri A . Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature . Biomaterials . 2014 ; 35 ( 5 ): 1643 ? 1656 . doi: 10.1016/j.biomaterials.2013.10.074 . 24239109 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로